Clicky

BioCryst Pharmaceuticals, Inc.(BCRX) News

Date Title
Jun 25 BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock?
Jun 13 Sector Update: Health Care Stocks Lean Lower Premarket Friday
Jun 13 ORLADEYO® (berotralstat) Approved in Colombia
Jun 13 United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?
Apr 10 How BioCryst Pharmaceuticals, Inc. (BCRX) Stock Stands Out in a Strong Industry
Mar 1 Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now?
Feb 27 BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Feb 26 Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom Fisher
Feb 26 Wall Street Analysts Predict an 84.18% Upside in BioCryst (BCRX): Here's What You Should Know
Feb 24 BioCryst: Q4 Earnings Snapshot
Feb 24 BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
Feb 24 BioCryst Announces Positive Results from APeX-P Trial for ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Aged 2 to <12 Years
Feb 17 BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Feb 12 BioCryst Launches ORLADEYO® (berotralstat) in Portugal
Feb 10 Exploring Three High Growth Tech Stocks In The United States
Feb 10 BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
Feb 10 BioCryst to Report Fourth Quarter 2024 Financial Results on February 24
Jan 14 BioCryst price target raised to $12 from $10 at Evercore ISI
Jan 10 Exploring High Growth Tech Stocks In January 2025
Jan 10 BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)